AstraZeneca
solid | AstraZeneca
Company
Deck Type
Sector
Industry
Deck date
November 2024
Slide
47 of 157
Similar slides by AstraZeneca
See diffirences between slides (animation)
Results
November 2024
factor inhibitor ophthalmology | AstraZeneca
Results
November 2024
factor inhibitor complement mediated disease | AstraZeneca
Results
November 2024
targeting complement nephrology | AstraZeneca
Results
November 2024
kidney targeted factor fusion protein nephrology | AstraZeneca
Related slides by other companies
Immix Biopharma
Investor Presentation
August 2023
direct path to line therapy in clinical trial plan cold | Immix Biopharma
Oculis
Investor Conference
June 2023
development status | Oculis
Exscientia
Investor Presentation
July 2023
elucidate phase ongoing in advanced solid | Exscientia
SentiBio
SPAC
October 2021
gene circuit enabled pipeline with additional collaboration opportunities | SentiBio
Other recent decks by AstraZeneca
See all presentations (31 decks)
Results
February 2025
Results
November 2024
Investor Event
September 2024
Results
February 2024
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights